Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis

K Takeda1, M Nakamoto, M Baba

  • 1Kidney Center, Saiseikai Yahata Hospital, Fukuoka, Japan.

Clinical Nephrology
|June 9, 1998
PubMed

Insights

Long-term peritoneal dialysis patients show worsening cardiac function, including left ventricular hypertrophy and systolic dysfunction. Poor blood pressure control, likely from overhydration, is a key factor, highlighting the importance of volume management in dialysis patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Dialysis patients exhibit high rates of left ventricular (LV) hypertrophy and systolic failure, critical for cardiovascular outcomes.
  • Continuous Ambulatory Peritoneal Dialysis (CAPD) and hemodialysis (HD) are common renal replacement therapies.
  • Long-term dialysis can impact cardiac structure and function.

Purpose of the Study:

  • To investigate cardiac function in long-term CAPD patients.
  • To compare cardiac function across different dialysis modalities and durations.
  • To identify factors contributing to cardiac dysfunction in CAPD patients.

Main Methods:

  • Echocardiography and pulsed Doppler were used to assess cardiac function in 17 long-term CAPD (L-CAPD), 16 short-term CAPD (S-CAPD), 21 long-term HD (L-HD), and 22 short-term HD (S-HD) patients.
  • Exclusion criteria included diabetes, ischemic heart disease, cardiac surgery, or overt congestive heart failure.
  • A control group of 13 normotensive patients with normal kidney function was included for comparison.

Main Results:

  • L-CAPD patients showed significantly worse blood pressure control, cardiothoracic rate, and ejection fraction compared to other groups.
  • The A/E ratio, indicating diastolic function, was higher in L-CAPD patients than in HD patients.
  • Left ventricular mass index (LVMI) was significantly higher in L-CAPD patients and worsened over time, suggesting progressive LV hypertrophy.

Conclusions:

  • Left ventricular hypertrophy and systolic dysfunction tend to progress in CAPD patients over time.
  • Poor blood pressure control, potentially due to overhydration, is a primary cause of cardiac dysfunction in CAPD.
  • Effective volume management is crucial for improving cardiovascular health in CAPD patients.

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...